{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T13:51:44Z","timestamp":1721569904578},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2000,2]]},"DOI":"10.1016\/s0145-2126(99)90169-8","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T22:34:50Z","timestamp":1027636490000},"page":"109-115","source":"Crossref","is-referenced-by-count":17,"title":["Malignant hematopoietic cell lines: in vitro models for the study of myelodysplastic syndromes"],"prefix":"10.1016","volume":"24","author":[{"given":"Hans G","family":"Drexler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0145-2126(99)90169-8_BIB1","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJM199905273402107","article-title":"Myelodysplasia","volume":"340","author":"Heaney","year":"1999","journal-title":"New Engl. J. Med."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB2","first-page":"216","article-title":"Primary clonal myelodysplastic syndromes","volume":"26","author":"Beris","year":"1989","journal-title":"Semin. Hematol."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB3","first-page":"284","article-title":"Myelodysplastic syndromes (preleukemia)","volume":"23","author":"Koeffler","year":"1986","journal-title":"Semin. Hematol."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/10428199509049764","article-title":"Epidemiological and etiological aspects of myelodysplastic syndromes","volume":"16","author":"Aul","year":"1995","journal-title":"Leuk. Lymph."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0145-2126(97)00089-1","article-title":"Increasing incidence of myelodysplastic syndromes: real or fictitious","volume":"22","author":"Aul","year":"1998","journal-title":"Leuk. Res."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/10428199409051647","article-title":"Myelodysplastic syndromes in childhood\u2014classification, epidemiology, and treatment","volume":"13","author":"Hasle","year":"1994","journal-title":"Leuk. Lymph."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB7","first-page":"1985","article-title":"Childhood monosomy 7: epidemiology, biology, and mechanistic implications","volume":"85","author":"Luna-Fineman","year":"1995","journal-title":"Leuk. Lymph."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood.V90.2.479","article-title":"Juvenile myelomonocytic leukemia","volume":"90","author":"Arico","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(99)90169-8_BIB9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"FAB co-operative group proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/10428199309148501","article-title":"Chronic myelomonocytic leukaemia (CMML)\u2014A myelodysplastic or myeloproliferative syndrome?","volume":"9","author":"Michaux","year":"1993","journal-title":"Leuk. Lymph."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB11","doi-asserted-by":"crossref","unstructured":"Third MIC Cooperative Study Group. Recommendations for a morphologic, immunologic, and cytogenetic (MIC) working classification of the primary and therapy-related myelodysplastic disorders. Cancer Genet Cytogenet 1988;32:1.","DOI":"10.1016\/0165-4608(88)90303-2"},{"key":"10.1016\/S0145-2126(99)90169-8_BIB12","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(99)90169-8_BIB13","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0145-2126(98)00112-X","article-title":"Apoptosis and its role in the myelodysplastic syndromes: Implications for disease natural history and treatment","volume":"22","author":"Greenberg","year":"1998","journal-title":"Leuk. Res."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB14","first-page":"1648","article-title":"A paradigm shift in myelodysplastic syndromes","volume":"10","author":"Raza","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/S0145-2126(99)90169-8_BIB15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/10428199609054847","article-title":"Clinical aspects, cytogenetics and disease evolution in myelodysplastic syndromes","volume":"23","author":"Ohyashiki","year":"1996","journal-title":"Leuk. Lymph."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0145-2126(97)00193-8","article-title":"Molecular features of primary MDS with cytogenetic changes","volume":"22","author":"Mecucci","year":"1998","journal-title":"Leuk. Res."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB17","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1182\/blood.V84.10.3253.3253","article-title":"The 5q- syndrome","volume":"84","author":"Boultwood","year":"1994","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(99)90169-8_BIB18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3109\/10428199809057556","article-title":"The unexplored 5q13 locus: a role in hematopoietic malignancies","volume":"30","author":"Castro","year":"1998","journal-title":"Leuk. Lymph."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/10428199509056846","article-title":"Molecular analysis of the 5q- chromosome","volume":"17","author":"Nagarajan","year":"1995","journal-title":"Leuk. Lymph."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0889-8588(18)30328-9","article-title":"Molecular genetic aspects of myelodysplastic syndromes","volume":"6","author":"Bartram","year":"1992","journal-title":"Hematol. Oncol. Clin. North. Am."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB21","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0145-2126(98)00109-X","article-title":"Molecular abnormalities in myeloid leukemias and myelodysplastic syndromes","volume":"22","author":"Sawyer","year":"1998","journal-title":"Leuk. Res."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB22","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.leu.2401043","article-title":"Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells","volume":"12","author":"Drexler","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/S0145-2126(99)90169-8_BIB23","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0145-2126(94)90103-1","article-title":"Leukemia cell lines: In vitro models for the study of chronic myeloid leukemia","volume":"18","author":"Drexler","year":"1994","journal-title":"Leuk. Res."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB24","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0145-2126(95)00036-N","article-title":"Leukemia cell lines: In vitro models for the study of acute promyelocytic leukemia","volume":"19","author":"Drexler","year":"1995","journal-title":"Leuk. Res."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB25","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/sj.leu.2401160","article-title":"Lymphoma cell lines: In vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas)","volume":"12","author":"Drexler","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/S0145-2126(99)90169-8_BIB26","first-page":"207","article-title":"Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia","volume":"23","author":"Drexler","year":"1999","journal-title":"Leuk. Res."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB27","first-page":"24","article-title":"In vitro differentiation of 2 myeloid leukemia cell lines and the effect of anti-proliferative activity by TGF-\u03b2","volume":"102","author":"Takiguchi","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB28","doi-asserted-by":"crossref","first-page":"27700","DOI":"10.1016\/S0021-9258(18)47042-1","article-title":"Erythropoietin-dependent induction of hemoglobin synthesis in a cytokine-dependent cell line M-TAT","volume":"269","author":"Minegishi","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB29","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1073\/pnas.89.21.9996","article-title":"Productive nonlytic human immunodeficiency virus type 1 replication in a newly established human leukemia cell line","volume":"89","author":"Banerjee","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0145-2126(99)90169-8_BIB30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2141.1994.tb04904.x","article-title":"Establishment and characterization of a novel myeloid cell line from the bone marrow of a patient with the myelodysplastic syndrome","volume":"87","author":"Tohyama","year":"1994","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB31","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1365-2141.1995.tb05391.x","article-title":"A novel factor-dependent human myelodysplastic cell line, MDS92, contains haemopoietic cells of several lineages","volume":"91","author":"Tohyama","year":"1995","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB32","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1182\/blood.V84.9.3086.3086","article-title":"Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromes","volume":"84","author":"Asimakopoulos","year":"1994","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(99)90169-8_BIB33","first-page":"227","article-title":"Establishment of a new myeloid cell line with i(17q) as the sole chromosomal anomaly from the bone marrow of a patient with myelodysplastic syndrome","volume":"51","author":"Mizobuchi","year":"1997","journal-title":"Acta. Medica. Okayama"},{"key":"10.1016\/S0145-2126(99)90169-8_BIB34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2141.1991.tb04412.x","article-title":"Establishment and characterization of a B-cell line derived from a patient with a myelodysplastic syndrome which expresses myelomonocytic and lymphoid markers","volume":"78","author":"Bergamaschi","year":"1991","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB35","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1182\/blood.V70.5.1665.1665","article-title":"Establishment and characterization of a human myeloid cell line from Philadelphia chromosome-negative myeloblastic leukemia arising in a patient with myelodysplastic syndrome","volume":"70","author":"McCarty","year":"1987","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(99)90169-8_BIB36","unstructured":"Drexler HG, Dirks WG, MacLeod RAF, Quentmeier H, Steube KG, Uphoff CC, editors. DSMZ Catalogue of Human and Animal Cell Lines, 7th Edition. Braunschweig, Germany: 1999."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB37","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1182\/blood.V81.11.3068.3068","article-title":"Autocrine and paracrine growth control by granulocyte-monocyte colony-stimulating factor of acute lymphoblastic leukemia cells","volume":"81","author":"Freedman","year":"1993","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(99)90169-8_BIB38","first-page":"903","article-title":"Lymphoid blast crisis of B-lineage phenotype with monosomy 7 in a patient with juvenile chronic myelogenous leukemia (JCML)","volume":"8","author":"Lau","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/S0145-2126(99)90169-8_BIB39","first-page":"884","article-title":"B-lineage lymphoid blast crisis in juvenile chronic myelogenous leukemia. II. Interleukin-1-mediated autocrine growth regulation of the lymphoblasts","volume":"9","author":"Attias","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/S0145-2126(99)90169-8_BIB40","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1038\/sj.leu.2401115","article-title":"Models of lineage switching in hematopoietic development: A new myeloid-committed eosinophil cell line (YJ) demonstrates trilineage potential","volume":"12","author":"Yamaguchi","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/S0145-2126(99)90169-8_BIB41","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/ijc.2910610223","article-title":"Establishment of human acute myelogenous leukemia lines secreting interleukin-1\u03b2 in SCID mice","volume":"61","author":"Giavazzi","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0145-2126(99)90169-8_BIB42","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1182\/blood.V78.9.2261.2261","article-title":"Establishment and erythroid differentiation of a cytokine-dependent human leukemic cell line F-36: A parental line requiring granulocyte-macrophage colony- stimulating factor or interleukin-3, and a subline requiring erythropoietin","volume":"78","author":"Chiba","year":"1991","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(99)90169-8_BIB43","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/sj.leu.2400633","article-title":"Cytokine response profiles of human myeloid factor-dependent leukemia cell lines","volume":"11","author":"Drexler","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/S0145-2126(99)90169-8_BIB44","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1046\/j.1365-2141.1998.00900.x","article-title":"Establishment of a novel human myeloid leukaemia cell line (FKH-1) with t(6;9(p23;q34) and the expression of dek-can chimaeric transcript","volume":"102","author":"Hamaguchi","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB45","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1365-2141.1997.2143029.x","article-title":"Establishment of a novel human myeloid leukaemia cell line (HNT-34) with t(3;3)(q21;q26), t(9;22)(q34;q11) and the expression of EVI1 gene, p210 and p190 BCR\/ABL chimaeric transcripts from a patient with AML after MDS with 3q21q26 syndrome","volume":"98","author":"Hamaguchi","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB46","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0145-2126(99)00168-X","article-title":"Establishment of a myelodysplastic syndrome (MDS)\/secondary AML-derived T lymphoid cell line K2-MDS","volume":"24","author":"Matsuda","year":"2000","journal-title":"Leuk. Res."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB47","doi-asserted-by":"crossref","unstructured":"Nishimaki J, Miyazawa K, Yaguchi M, Katagiri T, Kawanishi Y, Toyama K, Ohyashiki K, Hashimoto S, Nakaya K, Takiguchi T. Vitamin K2 induces apoptosis of a novel cell line established from a patient with myelodysplastic syndrome. Leukemia 1999 (in press).","DOI":"10.1038\/sj.leu.2401491"},{"key":"10.1016\/S0145-2126(99)90169-8_BIB48","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/sj.leu.2400768","article-title":"Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23)","volume":"11","author":"Matsuo","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/S0145-2126(99)90169-8_BIB49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/10428199709114174","article-title":"In vitro culture studies of childhood myelodysplastic syndrome: Establishment of the cell line MUTZ-1","volume":"25","author":"Steube","year":"1998","journal-title":"Leuk. Lymph."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB50","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/jcp.1041540225","article-title":"Relationship between c-KIT expression and proliferation in acute myeloblastic leukemia cell lines","volume":"154","author":"Tohda","year":"1993","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB51","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1182\/blood.V72.3.1029.bloodjournal7231029","article-title":"Surface antigenic profile and globin phenotype of two new human erythroleukemia lines: characterization and interpretations","volume":"72","author":"Papayannopoulou","year":"1988","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(99)90169-8_BIB52","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1046\/j.1365-2141.1997.2413058.x","article-title":"Alterations of p53 and Rb genes in a novel human GM-CSF-dependent myeloid cell line (OHN-GM) established from therapy-related leukaemia","volume":"98","author":"Nagai","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB53","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0925-5710(97)00106-0","article-title":"Alterations in the colorectal carcinoma gene and protein in a novel human myeloid leukemia cell line with trisomy 18 established from overt leukemia after myelodysplastic syndrome","volume":"67","author":"Hamaguchi","year":"1998","journal-title":"Int. J. Hematol."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB54","first-page":"1100","article-title":"A novel human myelomonocytoid cell line, P39\/Tsugane, derived from overt leukemia following myelodysplastic syndrome","volume":"75","author":"Nagai","year":"1984","journal-title":"Gann"},{"key":"10.1016\/S0145-2126(99)90169-8_BIB55","first-page":"1296","article-title":"The monocytic cell line SKM-1 strongly expresses the myeloperoxidase gene","volume":"6","author":"Kawaguchi","year":"1992","journal-title":"Leukemia"},{"key":"10.1016\/S0145-2126(99)90169-8_BIB56","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2141.1993.tb03334.x","article-title":"Establishment of a leukaemic cell line from a patient with acquisition of chromosomal abnormalities during disease progression in myelodysplastic syndrome","volume":"85","author":"Nakagawa","year":"1993","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB57","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2141.1991.tb07988.x","article-title":"Loss of multiple point mutations of ras genes associated with acquisition of chromosomal abnormalities during disease progression in myelodysplastic syndromes","volume":"77","author":"Nakagawa","year":"1991","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB58","first-page":"1865","article-title":"Establishment of cell lines from B-cell precursor acute lymphoblastic leukemia","volume":"7","author":"Zhang","year":"1993","journal-title":"Leukemia"},{"key":"10.1016\/S0145-2126(99)90169-8_BIB59","first-page":"4999","article-title":"Establishment of a leukemia cell line with i(12p) from a patient with a mediastinal germ cell tumor and acute lymphoblastic leukemia","volume":"54","author":"Downie","year":"1994","journal-title":"Cancer. Res."},{"key":"10.1016\/S0145-2126(99)90169-8_BIB60","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/sj.leu.2401428","article-title":"Guidelines for the characterization and publication of human malignant hematopoietic cell lines","volume":"13","author":"Drexler","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/S0145-2126(99)90169-8_BIB61","doi-asserted-by":"crossref","unstructured":"Drexler HG, Dirks WG, MacLeod RAF. False human hematopoietic cell lines: Cross-contaminations and misinterpretations. Leukemia (in press).","DOI":"10.1038\/sj.leu.2401510"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212699901698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212699901698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T16:41:59Z","timestamp":1620837719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212699901698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["S0145212699901698"],"URL":"https:\/\/doi.org\/10.1016\/s0145-2126(99)90169-8","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2000,2]]}}}